Latest Articles
- Portopulmonary hypertension: A focused review for the internist
Key aspects of screening, diagnosis, and treatment, and a review of the various pulmonary hemodynamic patterns encountered in patients with liver disease.
- Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
These conditions often co-exist and can have complex interactions. The progression of kidney disease increases the risk of major adverse cardiovascular events.
- Evaluating a low anion gap: A practical approach
In teaching and in practice, little attention is given to a low anion gap, an oversight that can result in a missed opportunity to diagnose acute or chronic disorders requiring treatment.
- Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
Research and robust data are still lacking regarding use of midodrine in this setting.
- vOka vaccine-associated disseminated varicella zoster
The patient had received the live attenuated vaccine 1 month before presentation. He had no history of varicella infection.
- Petaloid dermatosis affecting the scalp and genitalia
The patient had seen no improvement with a 2-week course of terbinafine cream.
- If a patient has cirrhosis, should I correct coagulation abnormalities before a minor invasive procedure?
Hemostatic abnormalities in cirrhosis can include thrombocytopenia, prolonged prothrombin time, prolonged activated partial thromboplastin time, elevated international normalized ratio, and decreased fibrinogen.
- A practical guide for buprenorphine initiation in the primary care setting
The authors review changes in prescribing laws and outline buprenorphine induction protocols that can be adopted in the primary care setting.

